Allianz Asset Management GmbH - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 275 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,032,252
-79.7%
50,158
-53.6%
0.00%
-77.8%
Q2 2023$5,078,630
+4.2%
108,010
-7.0%
0.01%0.0%
Q1 2023$4,874,620
+40.8%
116,173
+28.0%
0.01%
+28.6%
Q4 2022$3,461,586
+58.0%
90,760
+62.2%
0.01%
+75.0%
Q3 2022$2,191,000
-34.7%
55,948
-26.2%
0.00%
+33.3%
Q3 2021$3,357,000
+54.8%
75,768
+98.5%
0.00%
+50.0%
Q2 2021$2,168,000
-43.1%
38,178
-25.0%
0.00%
-50.0%
Q1 2021$3,810,000
+245.4%
50,908
+299.6%
0.00%
+300.0%
Q4 2020$1,103,000
-45.4%
12,740
-54.5%
0.00%
-50.0%
Q4 2019$2,021,000
-88.5%
27,995
-77.6%
0.00%
-88.2%
Q3 2019$17,578,000
-23.2%
125,019
-0.0%
0.02%
-19.0%
Q2 2019$22,892,000
+27.9%
125,029
+11.1%
0.02%
+16.7%
Q1 2019$17,904,000
+665.1%
112,569
+352.0%
0.02%
+500.0%
Q4 2018$2,340,000
-56.4%
24,904
-34.4%
0.00%
-40.0%
Q3 2018$5,366,000
-9.8%
37,9860.0%0.01%
-16.7%
Q2 2018$5,946,000
-17.0%
37,986
-14.6%
0.01%
-14.3%
Q1 2018$7,163,000
+939.6%
44,474
+962.4%
0.01%
+600.0%
Q4 2017$689,000
+44.4%
4,186
-45.3%
0.00%
Q3 2017$477,000
+30.7%
7,654
+67.2%
0.00%
Q2 2017$365,000
-33.0%
4,578
-40.3%
0.00%
-100.0%
Q1 2017$545,000
-90.7%
7,666
-94.5%
0.00%
-85.7%
Q3 2015$5,846,000
+47.1%
138,145
+153.8%
0.01%
+75.0%
Q2 2015$3,973,00054,4250.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders